A brain tumor can cause nosebleeds, but the connection is rarely a simple one. In the vast majority of cases, a nosebleed has nothing to do with a brain tumor. Epistaxis is one of the most common complaints in medicine, affecting roughly 60% of people at some point in their lives, and most episodes trace back to mundane causes like dry air, nose-picking, or allergies. The scenarios in which a tumor actually triggers nosebleeds tend to involve very specific anatomy: a growth near the base of the skull that invades the nasal passages, a tumor whose treatment disrupts blood vessels, or, in rare cases, rising pressure inside the skull that backs up into the veins draining the nose.
Tumors That Grow Directly Into the Nasal Passages
The clearest link between a tumor and nosebleeds involves growths that originate at or near the skull base and physically extend into the sinuses or nasal cavity. These are not conventional “brain tumors” in the way most people picture them, but they sit at the boundary between the brain and the nose, and some are classified under neuro-oncology because of their origin in neural tissue. When such a tumor develops its own blood supply inside the nasal passages, bleeding can become a recurring problem, sometimes for months or years before the tumor is identified.
Olfactory neuroblastoma is one of the best-documented examples. This rare malignant tumor arises from the olfactory epithelium, the tissue responsible for smell, which sits at the very top of the nasal cavity near a thin plate of bone called the cribriform plate. Because it grows in richly vascularized tissue with direct nasal exposure, about half of patients present with nosebleeds, and around 70% report one-sided nasal blockage.1Global Journal of Medical Research. Unmasking Olfactory Neuroblastoma: A Case of Rare Pediatric Tumour and the Diagnostic and Therapeutic Challenges Patients may also lose their sense of smell, develop headaches, or notice excessive tearing. The tumor can extend upward through the cribriform plate into the brain, which is why it straddles the line between a nasal tumor and an intracranial one. One case report describes a patient who presented with hemorrhage as the initial sign, underscoring how vascular these tumors can be.2PubMed Central. Esthesioneuroblastoma (olfactory neuroblastoma) with hemorrhage: an unusual presentation
Extracranial meningiomas are another, even rarer, possibility. Meningiomas normally grow from the membranes surrounding the brain and are among the most common intracranial tumors. In extremely unusual cases, one can arise outside the skull entirely and present as a nasal mass. A published case describes a 55-year-old woman who came to the emergency department with a nosebleed and turned out to have a seven-to-eight-year history of intermittent, self-resolving epistaxis. Biopsy of a mass found in her nose confirmed it was a meningioma.3PubMed Central. Primary Extracranial Meningioma as a very Rare Cause of Nasal Mass and Epistaxis in an Elderly Cases like this are vanishingly uncommon, but they illustrate how a tumor type most people associate with the brain can occasionally show up in the nose.
Pituitary Tumors and Erosion Through the Skull Base
Pituitary adenomas, tumors of the pea-sized gland at the base of the brain, sit in a bony pocket called the sella turcica, just above the sphenoid sinus. Most pituitary tumors grow slowly and cause hormonal problems or vision changes long before they affect the nasal area. But large or invasive adenomas can erode downward through the floor of the sella and into the sphenoid sinus, placing tumor tissue in direct contact with the nasal airway.
A striking pediatric case documented a child who experienced nosebleeds for eight months before anyone discovered a giant prolactinoma, a pituitary tumor that usually secretes the hormone prolactin. In this case, the tumor was invasive yet had normal prolactin levels, which made the diagnosis harder to reach. The epistaxis was the child’s very first clinical symptom, preceding any deterioration in vision.4PubMed Central. Epistaxis as first clinical presentation in a child with giant prolactinoma: Case report and review of literature This is the kind of case that reminds clinicians to keep skull-base tumors on the differential when recurrent nosebleeds resist easy explanation, even in young patients.
Can a Tumor Inside the Brain Cause Nosebleeds Indirectly?
Most brain tumors that stay within the skull and never touch the nasal passages will not cause nosebleeds. However, there is a theoretical mechanism involving intracranial pressure. A growing mass inside the skull can raise pressure on the brain, and that pressure can propagate through the venous system. The veins that drain the nasal mucosa connect, indirectly, to the venous sinuses inside the skull. If intracranial pressure spikes, it could in theory back up into these nasal veins and provoke bleeding.
Evidence for this pathway is thin and mostly speculative. One published case explored the idea in a patient with stabbing headaches followed immediately by nosebleeds. The authors proposed that sudden waves of raised venous pressure inside the skull could force open collapsed veins near the front of the face, and that this reopening might explain the tight sequence of headache, nosebleed, and then pain relief.5PubMed. Recurrent epistaxis following stabbing headache responsive to acetazolamide That patient did not have a tumor, but the proposed mechanism of raised intracranial venous pressure is the same one that would apply if a mass were the cause. The practical takeaway is that a conventional brain tumor sitting deep in the brain is an extremely unlikely explanation for nosebleeds unless there are other symptoms of raised pressure, like persistent headaches, nausea, or vision changes.
Aneurysms That Mimic Tumor-Related Bleeding
Not every intracranial cause of nosebleeds is a tumor. Internal carotid artery aneurysms, bulges in the wall of a major artery that runs through the base of the skull, can occasionally rupture into the sphenoid sinus and produce dramatic, even life-threatening nasal bleeding. Because the sphenoid sinus connects to the back of the nasal cavity, the blood exits through the nose, and the patient and the emergency team may initially assume it is a severe nosebleed from a mucosal source.
One case report describes a 64-year-old woman with a giant internal carotid aneurysm that ruptured into her nasal cavity, causing massive bleeding with no history of trauma.6PubMed. A case of internal carotid artery aneurysm diagnosed on basis of massive nosebleed Another documents a patient whose ruptured paraophthalmic carotid aneurysm initially presented as epistaxis along with dark stool, fainting, and dangerously low blood pressure, because much of the blood was being swallowed. CT angiography eventually revealed a 7 mm aneurysm projecting into an opacified sphenoid sinus.7PubMed Central. Hidden ruptured internal carotid artery aneurysm causing occult epistaxis, melena, syncope, and hemodynamic collapse: a case report These cases are rare, but they matter diagnostically because the treatment is completely different from packing a nose or cauterizing a vessel. When a nosebleed is massive, recurrent, and resistant to standard ENT management, imaging of the skull base and carotid arteries becomes important.
When Treatment for a Brain Tumor Causes Nosebleeds
Sometimes the tumor itself is not the direct cause of the bleeding, but the treatment is. This is especially relevant for glioblastoma, the most aggressive primary brain tumor in adults, which is often treated with bevacizumab, a drug that blocks the growth of new blood vessels. Bevacizumab is effective at starving tumors of their blood supply, but it also weakens blood vessels throughout the body. Nosebleeds are the most common hemorrhagic side effect, with reported rates of mild-to-moderate epistaxis ranging from about 5% to 26% of patients across studies.8The Oncologist. Practical Management of Bevacizumab-Related Toxicities in Glioblastoma – Section: Hemorrhage Most of these episodes are low-grade and manageable, but occasional cases reach a severity that warrants medical attention. In one study tracking glioma patients who received both bevacizumab and blood thinners, 20% experienced some form of hemorrhage, and one patient had grade 3 epistaxis severe enough to be classified as a serious adverse event.9PubMed. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients
Radiation therapy for tumors at or near the skull base can also set the stage for delayed nosebleeds, sometimes catastrophically. When radiation damages the walls of arteries over time, weakened spots can balloon into pseudoaneurysms. In patients treated for nasopharyngeal carcinoma, a cancer that sits at the back of the nasal cavity near the base of the skull, a retrospective analysis found that pseudoaneurysms in the internal or external carotid artery were a major cause of massive delayed epistaxis. Higher cancer stage, repeat radiation courses, and local bone destruction all increased the risk.10PubMed Central. Retrospective analysis of massive epistaxis and pseudoaneurysms in nasopharyngeal carcinoma after radiotherapy These bleeds can occur months or years after treatment and are considered emergencies.
How Doctors Investigate Recurrent or Severe Nosebleeds
If you are having nosebleeds that keep coming back without an obvious cause, or a single episode that is severe enough to send you to the emergency department, the diagnostic workup depends heavily on context. The vast majority of nosebleeds, even dramatic ones, turn out to have routine causes: a prominent vessel on the nasal septum, dry mucosa, blood-thinning medication, or uncontrolled blood pressure. Only about 6% of people who get nosebleeds end up seeking medical attention, and only a tiny fraction of those require hospitalization.11Sage Journals. Clinical Practice Guideline: Nosebleed (Epistaxis) – Section: OBJECTIVE
When imaging is performed, CT scans can sometimes reveal an underlying structural problem. A study of patients with either severe or recurrent epistaxis found a stark contrast between the two groups. Among patients with recurrent nosebleeds, CT identified a possible cause in every case, including tumors and inflammatory conditions. But among patients presenting with a single severe episode, CT found a relevant abnormality in fewer than 2% of cases. Of the 11 tumors identified in the study, 10 were in the recurrent-epistaxis group.12PubMed Central. Computed tomography findings in patients with primarily unknown causes of severe or recurrent epistaxis – Section: Results The implication is clear: a pattern of nosebleeds that keeps repeating is much more likely to have a structural cause than a single bad episode, no matter how frightening that single episode was.
For a primary care doctor or ENT specialist evaluating unexplained recurrent nosebleeds, the usual first step is direct examination of the inside of the nose with an endoscope. If a mass is visible, biopsy follows. If no source is apparent on examination and bleeding keeps recurring, CT or MRI of the sinuses and skull base is warranted. The imaging is looking not just for tumors but also for vascular malformations, aneurysms, and inflammatory disease. When a vascular cause is suspected, CT angiography provides a clearer picture of the arteries in the area.
Sinonasal and Skull-Base Lesions in Children and Adolescents
Parents searching this topic may be particularly anxious about a child with unexplained nosebleeds. Pediatric sinonasal and skull-base lesions are rare, and nosebleeds in children are overwhelmingly benign, most commonly caused by nose-picking and dry indoor air. When a tumor is responsible, it tends to follow a recognizable pattern. Juvenile nasopharyngeal angiofibroma, a benign but highly vascular tumor, occurs almost exclusively in adolescent males and typically presents with severe recurrent epistaxis along with nasal obstruction.13ScienceDirect. Pediatric sinonasal and skull base lesions Because the tumor is so vascular, the bleeding can be impressive and is often what prompts the initial workup.
Other pediatric skull-base tumors that can present with epistaxis include the olfactory neuroblastoma mentioned earlier and, rarely, invasive pituitary tumors. In the prolactinoma case discussed above, an eight-month delay between onset of nosebleeds and diagnosis highlights a practical challenge: children get nosebleeds all the time, so the symptom is easy to dismiss. The red flags that should prompt further investigation in a child are the same as in adults: nosebleeds that recur without a clear local cause, bleeding that is consistently one-sided, associated nasal obstruction, or any new neurological symptoms like headaches or vision changes.
When Emergency Intervention Is Needed for Tumor-Related Bleeding
Most tumor-related epistaxis does not arrive as a sudden gush but rather as a pattern of recurring, moderate bleeds. When massive hemorrhage does occur, though, it can be life-threatening and may require endovascular intervention rather than conventional nasal packing. A series of patients treated with endovascular embolization for severe head and neck bleeding included 15 with tumors, nine of whom had received prior radiation therapy. Two underwent palliative embolization for large, incurable bleeding tumors.14JAMA Network. Endovascular Treatment of Acute and Subacute Hemorrhage in the Head and Neck In these situations, interventional radiologists thread a catheter through the blood vessels and block the feeding artery supplying the tumor, stopping the bleed at its source.
For patients being treated with bevacizumab or similar anti-angiogenic drugs, the management of nosebleeds is usually straightforward: gentle pressure, humidification, and saline sprays. Treatment interruption is rarely needed for low-grade epistaxis. But when a patient on these drugs develops a nosebleed that does not stop with standard measures, or when the bleeding coincides with other symptoms like severe headache or confusion, prompt medical evaluation is important because the same drug that causes mucosal bleeding can also increase the risk of more serious intracranial hemorrhage.
Blood Disorders and Other Systemic Causes Worth Ruling Out
Before jumping to the conclusion that a brain tumor is behind your nosebleeds, it is worth knowing that several systemic conditions cause recurrent epistaxis far more commonly than any tumor does. Blood-thinning medications, including aspirin, warfarin, and the newer direct oral anticoagulants, are among the most frequent culprits. Liver disease, which impairs the production of clotting factors, and kidney disease, which affects platelet function, can both produce a bleeding tendency that shows up first in the nose because the nasal lining is so thin and vascular.
Hereditary hemorrhagic telangiectasia, sometimes called HHT or Osler-Weber-Rendu syndrome, is a genetic condition that causes fragile, abnormally formed blood vessels in the nose and elsewhere. People with HHT can have dozens of nosebleed episodes per month. Platelet disorders, von Willebrand disease, and other clotting-factor deficiencies also present with nosebleeds and are diagnosed with straightforward blood tests. A standard workup for unexplained recurrent epistaxis typically includes a complete blood count, coagulation studies, and liver and kidney function panels, all of which are far more likely to yield an answer than brain imaging in a patient with no neurological symptoms.
The pattern that should raise concern for a skull-base tumor specifically, as opposed to these systemic causes, is one-sided nasal obstruction accompanying the bleeds, loss of smell, facial pain or pressure that does not fit a sinus infection, or any new neurological finding like double vision, facial numbness, or a drooping eyelid. When nosebleeds occur in isolation with no other symptoms, a tumor is near the bottom of the list of likely explanations.